
Sandy Royden steps down from Huntsworth
pharmafile | February 9, 2010 | Appointment | Medical Communications | Huntsworth, appointment, medical communications
Huntsworth Health’s European chief executive Sandy Royden is stepping down at the end of March.
Sandy, who is expecting a baby in the summer, said she felt it was not possible to reconcile Huntworth’s move to a globally-focused company, and the transatlantic travel that involved, with her changing personal circumstances.
She joined Huntsworth Health in May 2005, subsequently leading the European integration and spearheading the delivery of the med coms, brand coms, digital, market access and more latterly the market research offerings.
Huntsworth Health chief executive Neil Matheson said: “Sandy’s leadership over the past few years has been a major factor in the success of Huntsworth Health Europe. I would like to thank Sandy for her contribution to our past success and wish her the best for the future.”
Related Content

Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.






